1,094
Views
13
CrossRef citations to date
0
Altmetric
Research Article

In vivo effect of surfactant on inflammatory cytokines during endotoxin-induced lung injury in rodents

&
Pages 274-283 | Received 07 Mar 2011, Accepted 23 May 2011, Published online: 18 Jul 2011

References

  • Arias-Diaz, J., Garcia-Verdugo, I., Casals, C., Sanchez-Rico, N., Vara, E. and Balibrea, J. L. 2000. Effect of surfactant protein A (SP-A) on the production of cytokines by human pulmonary macrophages. Shock. 14:300–306.
  • Baggiolini, M., Dewald, B. and Moser, B. 1997. Human chemokines: An update. Annu Rev Immunol. 15:675–705.
  • Balibrea, J. L. and Arias-Díaz, J. 2003. Acute respiratory distress syndrome in the septic surgical patient. World J Surg. 27:1275–1284.
  • Bastarache, J. A. and Blackwell, T. S. 2009. Development of animal models for the acute respiratory distress syndrome. Dis Model Mech. 2:218–223.
  • Becker, S. and Soukup, J. M. 1999. Exposure to urban air particulates alters the macrophage-mediated inflammatory response to respiratory viral infection. J Toxicol Environ Health Part A. 57:445–457.
  • Beck-Schimmer, B., Schwendener, R., Pasch, T., Reyes, L., Booy, C. and Schimmer, R. C. 2005. Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir Res. 6:61.
  • Borron, P., McIntosh, J. C., Korfhagen, T. R., Whitsett, J. A., Taylor, J. and Wright, J. R. 2000. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol. 278:L840–L847.
  • Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254.
  • Chabot, S., Salez, L., McCormack, F. X., Touqui, L. and Chignard, M. 2003. Surfactant protein A inhibits lipopolysaccharide-induced in vivo production of interleukin-10 by mononuclear phagocytes during lung inflammation. Am J Respir Cell Mol Biol. 28:347–353.
  • Chen, H., Bai, C. and Wang, X. 2010. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med. 4:773–783.
  • Donnelly, S. C., Haslett, C., Reid, P. T., Grant, I. S., Wallace, W. A., Metz, C. N., Bruce, L. J. and Bucala, R. 1997. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med. 3:320–323.
  • Galani, V., Tatsaki, E., Bai, M., Kitsoulis, P., Lekka, M., Nakos, G. and Kanavaros, P. 2010. The role of apoptosis in the pathophysiology of Acute Respiratory Distress Syndrome (ARDS): An up-to-date cell-specific review. Pathol Res Pract. 206:145–150.
  • Germann, P. G. and Häfner, D. 1998. A rat model of acute respiratory distress syndrome (ARDS): Part 1. Time dependency of histological and pathological changes. J Pharmacol Toxicol Methods. 40:101–107.
  • Gregory, T. J., Longmore, W. J., Moxley, M. A., Whitsett, J. A., Reed, C. R., Fowler, A. A. 3rd, Hudson, L. D., Maunder, R. J., Crim, C., and Hyers, T. M. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest. 88:1976–1981.
  • Hocke, A. C., Ermert, M., Althoff, A., Brell, B., N’Guessan, P. D., Suttorp, N. and Ermert, L. 2006. Regulation of interleukin IL-4, IL-13, IL-10, and their downstream components in lipopolysaccharide-exposed rat lungs. Comparison of the constitutive expression between rats and humans. Cytokine. 33:199–211.
  • Jacobs, R. F., Tabor, D. R., Burks, A. W. and Campbell, G. D. 1989. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis. 140:1686–1692.
  • Janssen, W. J., Barthel, L., Muldrow, A., Oberley-Deegan, R. E., Kearns, M. T., Jakubzick, C. and Henson, P. M. 2011. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am J Respir Crit Care Med. (In press).
  • Kinoshita, M., Mochizuki, H. and Ono, S. 1999. Pulmonary neutrophil accumulation following human endotoxemia. Chest. 116:1709–1715.
  • Kesecioglu, J., Schultz, M. J., Lundberg, D., Lauven, P. M., and Lachmann, B. 2001. Treatment of acute lung injury (ALI/ARDS) with surfactant. Am J Respir Crit Care Med. 163:A819.
  • Li, S. L., Wu, Z. H., Zhang, S. Q., Qin, C. P., Li, T., Chen, Z. T., Jin, J. S., MA, S. F. and Li, J. 2011. The changes in secretory function of pulmonary intravascular macrophages after challenge of lipopoly saccharide. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 23:176–178.
  • Lin, W. C., Lin, C. F., Chen, C. L., Chen, C. W. and Lin, Y. S. 2010. Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators. Exp Biol Med (Maywood.) 235:57–65.
  • Ma, X., Xu, D., Ai, Y., Ming, G. and Zhao, S. 2010. Fas inhibition attenuates lipopolysaccharide-induced apoptosis and cytokine release of rat Type II alveolar epithelial cells. Mol Biol Rep. 37:3051–3056.
  • Martin, T. R. 1997. Cytokines and the acute respiratory distress syndrome (ARDS): A question of balance. Nat Med. 3:272–273.
  • Martin, T. R., Donnelly, S. C., Steinberg, K. P., Ruzinski, J. T., Metz, C. N., Goodman, R. B., Hudson, L. D., and Bucala, R. 1998. Macrophage inhibitory factor (MIF) in the lungs of patients with acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med. 157:A459.
  • Matute-Bello, G., Frevert, C. W. and Martin, T. R. 2008. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 295:L379–L399.
  • McCormack, F. 1997. The structure and function of surfactant protein-A. Chest. 111:114S–119S.
  • McIntosh, J. C., Mervin-Blake, S., Conner, E. and Wright, J. R. 1996. Surfactant protein A protects growing cells and reduces TNF-α activity from LPS-stimulated macrophages. Am J Physiol. 271:L310–L319.
  • Mitchell, R. S. 1999. Lung cytokines and ARDS. Chest. 116:2S–8S.
  • Mittal, N. and Sanyal, S. N. 2009. Exogenous surfactant suppresses inflammation in experimental endotoxin-induced lung injury. J Environ Pathol Toxicol Oncol. 28:341–349.
  • Mittal, N., and Sanyal, S. N. 2010a. Cyclooxygenase inhibition enhances the effects of surfactant therapy in endotoxin induced rat model of ARDS. Inflammation; 34:92–98.
  • Mittal, N., and Sanyal, S. N. 2010b. Immunomodulatory properties of exogenous surfactant in adult rat alveolar macrophages. Immunopharm Immunotoxicol. 32:153–159.
  • Mittal, N., and Sanyal, S. N. 2010c. Intratracheal instillation of surfactant inhibits LPS-induced acute respiratory distress syndrome in rats. Am J Biomed Sci. 2:190–201.
  • Mittal, N., and Sanyal, S. N. 2011. Exogenous surfactant prevents the mitochondrial depolarization and changes in Ca2+ homeostasis due to oxidative stress leads to apoptosis in experimental lung injury. Inst Integr Omics Biotech. (In press).
  • Mirzapoiazova, T., Kolosova, I. A., Moreno, L., Sammani, S., Garcia, J. G. and Verin, A. D. 2007. Suppression of endotoxin-induced inflammation by taxol. Eur Respir J. 30:429–435.
  • Pittet, J. F., Mackersie, R. C., Martin, T. R. and Matthay, M. A. 1997. Biological markers of acute lung injury: Prognostic and pathogenetic significance. Am J Respir Crit Care Med. 155:1187–1205.
  • Pugin, J., Ricou, B., Steinberg, K. P., Suter, P. M. and Martin, T. R. 1996. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med. 153:1850–1856.
  • Temmesfeld-Wollbrück, B., Walmrath, D., Grimminger, F. and Seeger, W. 1995. Prevention and therapy of the adult respiratory distress syndrome. Lung. 173:139–164.
  • Thomassen, M. J., Antal, J. M., Barna, B. P., Divis, L. T., Meeker, D. P. and Wiedemann, H. P. 1996. Surfactant down-regulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts. Am J Physiol. 270:L159–L163.
  • Tomashefski, J. F. Jr. 2000. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 21:435–466.
  • Tutor, J. D., Mason, C. M., Dobard, E., Beckerman, R. C., Summer, W. R. and Nelson, S. 1994. Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med. 149:1107–1111.
  • Warren, H. S., Fitting, C., Hoff, E., Adib-Conquy, M., Beasley-Topliffe, L., Tesini, B., Liang, X., Valentine, C., Hellman, J., Hayden, D. and Cavaillon, J. M. 2010. Resilience to bacterial infection: Difference between species could be due to proteins in serum. J Infect Dis. 201:223–232.
  • Yamada, M., Kubo, H., Kobayashi, S., Ishizawa, K., He, M., Suzuki, T., Fujino, N., Kunishima, H., Hatta, M., Nishimaki, K., Aoyagi, T., Tokuda, K., Kitagawa, M., Yano, H., Tamamura, H., Fujii, N. and Kaku, M. 2011. The increase in surface CXCR4 expression on lung extravascular neutrophils and its effects on neutrophils during endotoxin-induced lung injury. Cell Mol Immunol. ( In press).
  • Yeh, C. C., Kao, S. J., Lin, C. C., Wang, S. D., Liu, C. J. and Kao, S. T. 2007. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci. 80:1821–1831.
  • Zhang, Q., Li, Q., Mao, B. L., Qian, G. S., Xu, J. C. and Chen, Z. T. 2004. Studies on the expression of mRNA of anti- and pro-inflammatory cytokines in acute lung injury induced by lipopolysaccharide in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 16:585–588.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.